Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pilot Assessment of Lopinavir/Ritonavir and Maraviroc (PALM)

This study has been terminated.
(unable to enroll expected number of subjects)
Information provided by (Responsible Party):
Barry M. Rodwick, M. D., Rodwick, Barry M., M.D. Identifier:
First received: September 19, 2009
Last updated: June 20, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2015
  Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)